Related Experiment Video
Updated: Apr 30, 2026
07:12
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
3.5K
[Treatment evaluation and clinical decision making using HKT-30-ROM]
Tijdschrift Voor Psychiatrie
|May 9, 2014
Summary
Visualizing behavioral changes using the Historical, Clinical and Future - 30 (HKT-30) indicators aids treatment evaluation. This method enhances clinical decision-making and client-therapist dialogue in forensic psychiatric care.
Area of Science:
- Forensic Psychiatry
- Clinical Psychology
- Treatment Evaluation
Background:
- Clinical dynamic indicators, such as the Historical, Clinical and Future - 30 (HKT-30), enable monitoring of behavioral changes related to risks and needs.
- Additional scoring parameters refine the identification of client-specific risks and needs.
- Visualizing changes in these indicators is crucial for effective treatment evaluation and clinical decision-making in rehabilitation.
Observation:
- A case study at the Forensic Psychiatric Clinic (FPK) demonstrates the application of HKT-30 indicators.
- Clinicians use these indicators to assess and clarify risks, needs, and behavioral changes.
- This process supports treatment evaluation and clinical decision-making.
Findings:
- Routine treatment evaluation using visualized HKT-30 indicators provides clarity on behavioral changes targeted by forensic treatment.
- This visualization offers significant starting points for clinical decision-making.
Implications:
- Adjusted HKT-30 indicators enhance the visibility of behavioral changes during routine treatment evaluation.
- This transparency in clinical decisions facilitates a more productive dialogue with clients regarding their treatment and progress.
More Related Videos
Related Concept Videos
01:12Hazard Ratio
756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
756
01:29Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342
01:16Therapeutic Drug Monitoring: Overview and Classification
642
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
642
01:15Nursing Evaluation
4.1K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
4.1K